Review article: Risks of coronary artery calcification in chronic kidney disease: do the same rules apply?

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pathology

Background:

• Atherosclerosis involves calcification in the intimal and medial layers of blood vessels.
• Vascular calcification is notably accelerated and amplified in patients with chronic kidney disease (CKD).
• Calcium hydroxyapatite deposition is a permanent feature of mature atherosclerotic plaques, resistant to current treatments.

Purpose of the Study:

• To review the distinct characteristics of vascular calcification in CKD patients compared to the general population.
• To examine the natural history of vascular calcification in CKD.
• To discuss the implications for therapeutic strategies and expected outcomes in CKD.

Main Methods:

• Review of existing literature on atherosclerosis and vascular calcification.
• Comparison of observational and interventional studies in CKD and general populations.
• Analysis of cellular and metabolic processes contributing to calcification.

Main Results:

• CKD patients exhibit significantly accelerated and amplified vascular calcification.
• Circumferential calcification may cause stenosis but reduces the risk of acute coronary syndromes due to plaque rupture.
• Established treatment protocols for atherosclerosis do not effectively modify calcification in CKD.

Conclusions:

• Vascular calcification in CKD presents unique challenges and differs substantially from the general population.
• The irreversibility of calcification impacts treatment efficacy and patient outcomes.
• Further research is needed to develop targeted therapies for vascular calcification in CKD.